In general, human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) 1 can be cultured under variable conditions.
However, it is not easy to establish an effective system for culturing these cells. Since the culture conditions can influence gene expression that confers pluripotency in hESCs and hiPSCs, the optimization and standardization of the culture method is crucial.
The establishment of hESC lines was first described by using MEFs as feeder cells and fetal bovine serum (FBS)-containing culture medium 2 . Next, FBS was replaced with knockout serum replacement (KSR) and FGF2, which enhances proliferation of hESCs 3 . Finally, feeder-free culture systems enable culturing cells on Matrigel-coated plates in KSR-containing conditioned medium (medium conditioned by MEFs) 4 . Subsequently, hESCs culture conditions have moved towards feeder-free culture in chemically defined conditions [5] [6] [7] . Moreover, to avoid the potential contamination by pathogens and animal proteins culture methods using xeno-free components have been established 8 .
To obtain improved conditions mouse feeder cells have been replaced with human cell lines (e.g. fetal muscle and skin cells 9 , adult skin cells 10 , foreskin fibroblasts [11] [12] , amniotic mesenchymal cells 13 ). However, the efficiency of maintaining undifferentiated hESCs using human foreskin fibroblast-derived feeder layers is not as high as that from mouse feeder cells due to the lower level of secretion of Activin A
14
. Obviously, there is an evident difference in growth factor production by mouse and human feeder cells.
Analyses of the transcriptomes of mouse and human feeder cells revealed significant differences between supportive and non-supportive cells. Exogenous FGF2 is crucial for maintaining self-renewal of hESCs and hiPSCs, and has been identified as a key factor regulating the expression of Tgfβ1, Activin A and Gremlin (a BMP antagonist) in feeder cells. Activin A has been shown to induce the expression of OCT4, SOX2, and NANOG in hESCs [15] [16] . For long-term culture, hESCs and hiPSCs can be grown on mitotically inactivated MEFs or under feeder-free conditions in MEF-CM (MEFConditioned Medium) on Matrigel-coated plates to maintain their undifferentiated state. Success of both culture conditions fully depends on the quality of the feeder cells, since they directly affect the growth of hESCs.
Here, we present an optimized method for the isolation and culture of mouse embryonic fibroblasts (MEFs), preparation of conditioned medium (CM) and enzyme-linked immunosorbent assay (ELISA) to assess the levels of Activin A within the media.
Video Link
The video component of this article can be found at http://www.jove.com/video/3854/ Protocol
Isolation of Mouse Embryonic Fibroblasts (MEFs)
The following two steps are performed under non-aseptic conditions. The following steps are carried out in a tissue culture hood under aseptic conditions and using sterile instruments. MEF culture medium (components to make 500 ml of media, mix all components and filter): 450 ml of DMEM, 50 ml of FBS (10% (v/v)), 5 ml of 200 mM L-glutamine (1/100 (v/v)), 5 ml of Penicillin-streptomycin (1/100 (v/v)). 8. Centrifuge the cells with low-speed (300 x g), 5 min, carefully remove the supernatant and resuspend cell pellet in warm MEF medium. 9 . Plate approximately a number of cells which is equivalent to 3-4 embryos in each T150 (TPP) flask coated with 0.2% gelatine (Gelatine from bovine skin, Type B, Sigma) for 2 hr. The fibroblasts (P0, passage 0) are the only cells that have the ability to attach to the gelatine-coated flasks. 10. Ideally, cells are 80-90% confluent after 24 hr and at this stage a major part of P0 cells is frozen for future usage. 11. Expand the remaining T150 flask(s) of P0 cells till P3 or P4, then inactivate and use as feeders to replate hESCs or to produce conditioned medium (CM).
Inactivation and Plating MEFs (Feeder Cells Preparation)
All steps are carried out in a tissue culture hood under aseptic conditions. . 4. Place 20 ml of medium containing 10 μg/ml of mitomycin C on MEFs. 5. Incubate for 2 hr at 37 °C with mitomycin C containing medium then wash twice with PBS, trypsinize, centrifuge (for 5 min at 300 x g) and resuspend cells in warm medium. 6. Count cells and plate at a density of 56.000 cells/cm 2 in T150 flasks and use for CM production for the following 6 days.
Conditioned Medium (CM) Preparation
All steps are carried out in a tissue culture hood under aseptic conditions.
1. The day after plating inactivated MEFs at a density of 56.000 cells/cm 2 replace the MEF medium with hESC medium (UM, unconditioned medium) (0.5 ml/cm 2 ) supplemented freshly with 4 ng/ml of FGF2. 2. Collect CM from feeder flasks after 24 h incubation and add fresh hESC medium containing 4 ng/ml of FGF2 to the feeders. 3. Repeat this procedure for the next 6 days. Each day store collected CM at -20 °C. 4. After 6 days mix all aliquots of medium and filter (Corning, 0.22 μm, PAS). Make 50 ml aliquots and store at -80 °C. 5. Supplement CM with additional 4 ng/ml of FGF2 before adding to hESCs grown on Matrigel. 15 1. Bring all samples and reagents to room temperature. 2. Dilute capture antibody (Human\Mouse\Rat Activin A MAb, R&D Systems) in PBS with 1% BSA, add to microplate (100 μl/well) and incubate overnight at RT. 3. After 24 hr wash the wells three times with PBST (PBS with 0.05% Tween 20) (300 μl/well) then block (1% BSA/PBS, 300 μl/well) for 1 hr at RT. 4. In this time prepare an Activin A (R&D Systems) standard curve, including 7 dilutions (concentration less than 30 ng/ml) and blank sample.
Measurement of Activin A in Conditioned Media (ELISA)
The linear working range of the Activin A is between 0.25 and 32 ng/ml. 5. Add duplicates of standards and samples to the wells (100 μl/well) and incubate for 2 hr at RT. 6. Wash wells three times (300 μl of PBST). 7. Add the secondary (biotinylated) antibody (Human/Mouse/Rat Biotinylated Activin A MAb, R&D Systems) (0.25 μg/ml in 1% BSA/PBS) and incubate for 2 hr at RT. 8. Wash wells three times (300 μl of PBST), add Streptavidin-HRP (diluted in 1%BSA/PBS, R&D Systems) and incubate for 20 min at RT. 9. Wash wells three times (300 μl of PBST), add 100 μl of substrate solution (Quantikine, R&D Systems) and incubate for 30 min at RT in the dark. 10. Add 100 μl of stop solution (Quantikine, R&D Systems) to each well and mix gently. 11. Set Microplate reader (Molecular Devices Spectra Max 250, Global Medical Instrumentation, Inc., Minnesota) to 450 nm, with wavelength correction at 540 or 570 nm, to determine the optical density of each well.
Representative Results
The overall scheme of the isolation procedure is presented in Figure 1 . The typical morphology of hESCs and hiPSCs cultured under different conditions is presented in Figure 2 . The morphology of MEFs and inactivated feeder cells used to prepare CM is presented in Figure 3 . In general, cells should be confluent 24 hours post-isolation and ready to be frozen or expanded. However, sometimes it might take 2-3 days before obtaining confluent cultures. The CM should be prepared from cells at passage 4 and not later. This is crucial because primary cells can only be expanded for 4-5 passages before the onset of senescence.
